Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses
NCT03185871Phase 2Withdrawn
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of celecoxib oral solution in breast carcinoma, sponsored by University of Wisconsin–Madison. Planned start Sep 2017; status: withdrawn.
02
Drugs
celecoxib oral solution
03
Conditions
breast carcinoma
Beyond the preview
Go deeper on NCT03185871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03185871.